Page 4 - Oblte News Today

Belite Bio (NASDAQ:BLTE – Get Rating) had its target price reduced by HC Wainwright from $58.00 to $55.00 in a report issued on Monday, The Fly reports. HC Wainwright also issued estimates for Belite Bio’s Q2 2023 earnings at ($0.18) EPS, Q3 2023 earnings at ($0.19) EPS, Q4 2023 earnings at ($0.21) EPS, FY2023 earnings […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) – Research analysts at HC Wainwright issued their Q1 2024 EPS estimates for Belite Bio in a report released on Monday, June 5th. HC Wainwright analyst Y. Chen expects that the company will earn ($0.23) per share for the quarter. The consensus estimate for Belite Bio’s current full-year […]

Belite Bio (NASDAQ:BLTE – Get Rating) had its price target reduced by equities researchers at HC Wainwright from $58.00 to $55.00 in a research note issued on Monday, The Fly reports. HC Wainwright’s target price suggests a potential upside of 264.24% from the company’s previous close. HC Wainwright also issued estimates for Belite Bio’s Q1 […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) was the recipient of a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 27,200 shares, a decrease of 18.6% from the April 30th total of 33,400 shares. Based on an average daily volume of 11,900 shares, the […]

Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Rating) were up 4.6% during mid-day trading on Wednesday . The company traded as high as $24.23 and last traded at $23.80. Approximately 4,581 shares were traded during mid-day trading, a decline of 55% from the average daily volume of 10,247 shares. The stock had previously closed […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) shares saw unusually-high trading volume on Monday . Approximately 5,918 shares were traded during trading, a decline of 40% from the previous session’s volume of 9,866 shares.The stock last traded at $26.15 and had previously closed at $25.54. Analysts Set New Price Targets A number of equities analysts […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) shares gapped up before the market opened on Friday . The stock had previously closed at $26.22, but opened at $27.03. Belite Bio shares last traded at $26.75, with a volume of 1,504 shares traded. Wall Street Analysts Forecast Growth Several analysts have recently issued reports on the […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) gapped up prior to trading on Wednesday . The stock had previously closed at $27.59, but opened at $29.20. Belite Bio shares last traded at $29.20, with a volume of 485 shares trading hands. Analyst Ratings Changes BLTE has been the subject of a number of analyst reports. […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 31,700 shares, a growth of 13.6% from the March 31st total of 27,900 shares. Based on an average trading volume of 10,500 shares, the short-interest ratio is […]

Belite Bio, Inc (NASDAQ:BLTE – Get Rating) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 31,700 shares, an increase of 13.6% from the March 31st total of 27,900 shares. Based on an average daily volume of 10,500 shares, the days-to-cover ratio is […]